Abstract 2113P
Background
Cisplatin-induced nephrotoxicity (CIN) is a frequent dose-limiting adverse effect, and many nephroprotective strategies have been proposed to prevent its occurrence. Although multiple studies support premedication with magnesium (Mg) and hydration, this intervention has not been widely implemented, as some centers still replace it only after the occurrence of hypomagnesemia. We performed a systematic review and meta-analysis to evaluate the efficacy and effectiveness of Mg supplementation (suppl) prior to cisplatin.
Methods
We systematically searched Pubmed, Embase, and Cochrane databases for randomized clinical trials (RCT) and observational studies assessing prophylactic Mg suppl compared with placebo for patients receiving cisplatin-based chemotherapy. Primary outcomes were acute nephrotoxicity and hypomagnesemia events; secondary outcome included the association of CIN with variations on serum creatinine levels (ΔSCr). We used RevMan 5.1.7 and RStudio for statistical analysis; random-effects models to pool studies; and I2 statistics to assess heterogeneity.
Results
We included 24 studies with 3,803 patients. Nine were RCT and 15 observational cohort studies. We found a significant reduction of risk of CIN (all grades) in patients treated with prophylactic Mg compared to placebo (OR = 0.16; 95%CI 0.11 – 0.24; p<0.001). The pooled analysis including only studies adjusted for confounding variables demonstrated a 67% risk reduction of CIN with Mg suppl (p<0.0001). Mg prophylaxis was effective in both the clinical trial setting (OR = 0.22) and in the real-world data analysis (OR = 0.15). The benefit was seen across all tumor types and combinations of cisplatin-based chemotherapies included in the study. Hypomagnesemia events were significantly less frequent in the intervention group (OR = 0.27; 95%CI 0.16–0.45; p<0.000001). There was no difference regarding doses of Mg administered, and the ΔSCr were not significantly associated with the risk of CIN.
Conclusions
In patients undergoing cisplatin-based chemotherapy, prophylactic Mg suppl significantly reduces the risk of CIN and hypomagnesemia as compared with no prophylaxis.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2076P - Topical diclofenac for prevention of HFS in patients receiving capecitabine monotherapy: An exploratory subgroup analysis of the D-ToRCH phase III trial
Presenter: Akhil Santhosh
Session: Poster session 06
2077P - A randomized, placebo-controlled trial assessing the efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, B1, B2, B6, E, Mg, Zn and a fatty acid for 6 months in the management of chemotherapy induced neuropathic pain
Presenter: Triantafylos Didangelos
Session: Poster session 06
2078P - Evaluation of chemotherapy-induced nausea and vomiting beyond the delayed phase: Results of a survey of healthcare providers in Japan
Presenter: Florian Scotté
Session: Poster session 06
2079P - Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)
Presenter: Maria del Carmen Beato Zambrano
Session: Poster session 06
2080P - Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data
Presenter: Olivia Rohr
Session: Poster session 06
2081P - The therapeutic effect of anti-inflammatory tripeptide cream on hand-foot syndrome related to anticancer drugs: A prospective, randomized, placebo-controlled pilot trial
Presenter: Yaewon Yang
Session: Poster session 06
2082P - TASMAN: An international survey on the knowledge, aTtitudes and clinical pAtternsS of use of Medical Cannabis for caNcer care
Presenter: Marco Filetti
Session: Poster session 06
2083P - Association between VTE location and risk of recurrent, bleeding and death in the international prospective TESEO SEOM cancer cohort
Presenter: Rocío Martín Lozano
Session: Poster session 06
2084P - Cardiovascular (CV) mortality among metastatic cancer patients: A retrospective cohort study
Presenter: Irbaz Riaz
Session: Poster session 06